Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Apocynin may protect skin cells from aging and damage caused by UVB light.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

A new treatment for hair loss shows promise with fewer side effects.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Doxazosin may cause breast enlargement and pain in men.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Alpha-blockers and Finasteride effectively manage BPH symptoms long-term.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Radiation from a medical procedure caused temporary hair loss, but hair regrew with treatment.

Peficitinib can turn human fibroblasts into cells that help grow hair.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Arabidopsis Formin 2 stabilizes actin filaments to aid cell-to-cell trafficking.